1[1]Charloux A, Quoix E,Wolkove N et al. The increasing incidence of lung adenocarcinoma: reality or artefact? a review of the epidemiology of lung adenocarcinoma. Int J Epidemiol, 1997;26:14～23
2[2]Charlonx A, Rossignol M, Purohit A et al. International differences in epidemiology of lung adenocarcinoma. Lung Cancer, 1997;16:133～43
4[4]Granata C, Gambini C, Balducci T et al. Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation. Pediatr Pulmonol, 1998;25(1);62～6
5[5]Yokozaki M, Kodama T, Yokose T et al. Differenetation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA Ploidy and morphometric analysis. Mod Pathol, 1996;9:1156～64
6[6]Cooper CA, Carby FA, Bubb VJ et al. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumor development in the human lung. J Pathol, l997;181:401～4
7[7]Yokozaki M, KodaJna T, Yokose T et al. Differnetiation of atyical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA and morphometric analysis. Mod Pathol, 1996;9:1156～64
8[8]Ohori NP, Yousem SA, Griffin J et al. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. An immumohistochemical study. Am J Surg Pathol, 1992;16:675～86
9[9]Hidaka N, Nagao T, Asoh A et al. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Mod Pathol, 1998;11(11):1039～45
10[10]Travis WD, Linnoila RI, Horowitz M et al. Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. Mod Pathol,1988;1:372～7
